Breakout in Alembic Pharma
* Analysis: Beautiful Range Breakout on a Daily & Weekly Candles for Alembic Pharma.
* Also the Stock has broke and moved above 200EMA on daily candle this month as is sustaining the same.
* One can plan a good 1:1 and 1:2 trade initially keeping the last swing low.
* The stock might face a little resistance while trying to move above 200EMA for weekly candle.
* One can also look for higher targets post 1:2 however make sure to use trailing stop loss for the same.
* Do invest only based on the risk which can be taken based on risk per trade process.
Note: This information is for entertainment purpose only and should not be treated as any trade recommendation. Please do research and consult your advisor prior to taking any actions.
If you like this Idea, Please do like my ideas and share it with your friends. To further connect check my bio.
Please boost my ideas and send cheers as it acts as a motivation to keep posting my analysis.
Thank you
* Also the Stock has broke and moved above 200EMA on daily candle this month as is sustaining the same.
* One can plan a good 1:1 and 1:2 trade initially keeping the last swing low.
* The stock might face a little resistance while trying to move above 200EMA for weekly candle.
* One can also look for higher targets post 1:2 however make sure to use trailing stop loss for the same.
* Do invest only based on the risk which can be taken based on risk per trade process.
Note: This information is for entertainment purpose only and should not be treated as any trade recommendation. Please do research and consult your advisor prior to taking any actions.
If you like this Idea, Please do like my ideas and share it with your friends. To further connect check my bio.
Please boost my ideas and send cheers as it acts as a motivation to keep posting my analysis.
Thank you
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.